To cope with the heterogeneity and get reliable HER2 results, we were the first to propose the idea of dual block HER2 assessment (using 2 primary tumor-containing blocks in the IHC staining of HER2) in resected specimens of GC [21]. This evidence concerns the gene ERBB2 and gastric cancer.